Concepts in sumoylation: a decade on (original) (raw)

• Meluh, P. B. & Koshland, D. Evidence that the MIF2 gene of Saccharomyces cerevisiae encodes a centromere protein with homology to the mammalian centromere protein CENP-C. Mol. Biol. Cell 6, 793–807 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Shen, Z., Pardington-Purtymun, P. E., Comeaux, J. C., Moyzis, R. K. & Chen, D. J. UBL1, a human ubiquitin-like protein associating with human RAD51/RAD52 proteins. Genomics 36, 271–279 (1996).
  Article CAS PubMed Google Scholar
• Okura, T. et al. Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J. Immunol. 157, 4277–4281 (1996).
  CAS PubMed Google Scholar
• Boddy, M. N., Howe, K., Etkin, L. D., Solomon, E. & Freemont, P. S. PIC1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene 13, 971–982 (1996).
  CAS PubMed Google Scholar
• Matunis, M. J., Coutavas, E. & Blobel, G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135, 1457–1470 (1996). Identifies SUMO1 as a reversible modifier, together with reference 6, and demonstrates that sumoylation can lead to altered localization.
  Article CAS PubMed Google Scholar
• Mahajan, R., Delphin, C., Guan, T., Gerace, L. & Melchior, F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88, 97–107 (1997). Identifies SUMO1 as a reversible modifier, together with reference 5, and demonstrates that sumoylation can lead to novel protein interactions.
  Article CAS PubMed Google Scholar
• Gill, G. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 15, 536–541 (2005).
  Article CAS PubMed Google Scholar
• Scheschonka, A., Tang, Z. & Betz, H. Sumoylation in neurons: nuclear and synaptic roles? Trends Neurosci. 30, 85–91 (2007).
  Article CAS PubMed Google Scholar
• Johnson, E. S. Protein modification by SUMO. Annu. Rev. Biochem. 73, 355–382 (2004).
  Article CAS PubMed Google Scholar
• Melchior, F., Schergaut, M. & Pichler, A. SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem. Sci. 28, 612–618 (2003).
  Article CAS PubMed Google Scholar
• Boggio, R. & Chiocca, S. Viruses and sumoylation: recent highlights. Curr. Opin. Microbiol. 9, 430–436 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Girdwood, D. W., Tatham, M. H. & Hay, R. T. SUMO and transcriptional regulation. Semin. Cell Dev. Biol. 15, 201–210 (2004).
  Article CAS PubMed Google Scholar
• Seeler, J. S. & Dejean, A. Nuclear and unclear functions of SUMO. Nature Rev. Mol. Cell Biol. 4, 690–699 (2003).
  Article CAS Google Scholar
• Bayer, P. et al. Structure determination of the small ubiquitin-related modifier SUMO-1. J. Mol. Biol. 280, 275–286 (1998).
  Article CAS PubMed Google Scholar
• Mossessova, E. & Lima, C. D. Ulp1–SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast. Mol. Cell 5, 865–876 (2000).
  Article CAS PubMed Google Scholar
• Bernier-Villamor, V., Sampson, D. A., Matunis, M. J. & Lima, C. D. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell 108, 345–356 (2002). The crystal structure reported in this paper demonstrates how the single E2 conjugating enzyme UBC9 recognizes conventional SUMO-acceptor sites in its targets.
  Article CAS PubMed Google Scholar
• Guo, D. et al. A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetes. Nature Genet. 36, 837–841 (2004).
  Article CAS PubMed Google Scholar
• Melchior, F. SUMO — nonclassical ubiquitin. Annu. Rev. Cell Dev. Biol. 16, 591–626 (2000).
  Article CAS PubMed Google Scholar
• Saitoh, H. & Hinchey, J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275, 6252–6258 (2000).
  Article CAS PubMed Google Scholar
• Rosas-Acosta, G., Russell, W. K., Deyrieux, A., Russell, D. H. & Wilson, V. G. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol. Cell Proteomics 4, 56–72 (2005).
  Article CAS PubMed Google Scholar
• Vertegaal, A. C. et al. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol. Cell Proteomics 5, 2298–2310 (2006).
  Article CAS PubMed Google Scholar
• Owerbach, D., McKay, E. M., Yeh, E. T., Gabbay, K. H. & Bohren, K. M. A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. Biochem. Biophys. Res. Commun. 337, 517–520 (2005).
  Article CAS PubMed Google Scholar
• Johnson, E. S., Schwienhorst, I., Dohmen, R. J. & Blobel, G. The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J. 16, 5509–5519 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Fraser, A. G. et al. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408, 325–330 (2000).
  Article CAS PubMed Google Scholar
• Saracco, S. A., Miller, M. J., Kurepa, J. & Vierstra, R. D. Genetic analysis of sumoylation in Arabidopsis: heat-induced conjugation of SUMO1 and 2 is essential. Plant Physiol. 145, 119–134 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Nacerddine, K. et al. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev. Cell 9, 769–779 (2005).
  Article CAS PubMed Google Scholar
• Tanaka, K. et al. Characterization of a fission yeast SUMO-1 homologue, Pmt3p, required for multiple nuclear events, including the control of telomere length and chromosome segregation. Mol. Cell. Biol. 19, 8660–8672 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Alkuraya, F. S. et al. SUMO1 haploinsufficiency leads to cleft lip and palate. Science 313, 1751 (2006). Finds reduced SUMO1 expression in a patient with cleft lip and shows that mice with one defective SUMO1 allele develop a similar phenotype. Moreover, it shows that SUMO1 is essential in mice.
  Article PubMed Google Scholar
• Desterro, J. M., Rodriguez, M. S., Kemp, G. D. & Hay, R. T. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J. Biol. Chem. 274, 10618–10624 (1999).
  Article CAS PubMed Google Scholar
• Okuma, T., Honda, R., Ichikawa, G., Tsumagari, N. & Yasuda, H. In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2. Biochem. Biophys. Res. Commun. 254, 693–698 (1999).
  Article CAS PubMed Google Scholar
• Gong, L., Li, B., Millas, S. & Yeh, E. T. Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex. FEBS Lett. 448, 185–189 (1999).
  Article CAS PubMed Google Scholar
• Johnson, E. S. & Blobel, G. Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J. Biol. Chem. 272, 26799–26802 (1997).
  Article CAS PubMed Google Scholar
• Desterro, J. M., Thomson, J. & Hay, R. T. Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 417, 297–300 (1997).
  Article CAS PubMed Google Scholar
• Lee, G. W. et al. Modification of Ran GTPase-activating protein by the small ubiquitin-related modifier SUMO-1 requires Ubc9, an E2-type ubiquitin-conjugating enzyme homologue. J. Biol. Chem. 273, 6503–6507 (1998).
  Article CAS PubMed Google Scholar
• Saitoh, H. et al. Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2. Curr. Biol. 8, 121–124 (1998).
  Article CAS PubMed Google Scholar
• Hochstrasser, M. SP-RING for SUMO: new functions bloom for a ubiquitin-like protein. Cell 107, 5–8 (2001).
  Article CAS PubMed Google Scholar
• Sharrocks, A. D. PIAS proteins and transcriptional regulation — more than just SUMO E3 ligases? Genes Dev. 20, 754–758 (2006).
  Article CAS PubMed Google Scholar
• Johnson, E. S. & Gupta, A. A. An E3-like factor that promotes SUMO conjugation to the yeast septins. Cell 106, 735–744 (2001). Together with reference 39 describes the first SUMO E3 ligases, Siz1 and Siz2. Identification of their mammalian homologues, the PIAS proteins, as E3 ligases followed shortly thereafter (see references 40 and 45).
  Article CAS PubMed Google Scholar
• Takahashi, Y., Kahyo, T., Toh, E. A., Yasuda, H. & Kikuchi, Y. Yeast Ull1/Siz1 is a novel SUMO1/Smt3 ligase for septin components and functions as an adaptor between conjugating enzyme and substrates. J. Biol. Chem. 276, 48973–48977 (2001).
  Article CAS PubMed Google Scholar
• Kahyo, T., Nishida, T. & Yasuda, H. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell 8, 713–718 (2001).
  Article CAS PubMed Google Scholar
• Schmidt, D. & Muller, S. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc. Natl Acad. Sci. USA 99, 2872–2877 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Nishida, T. & Yasuda, H. PIAS1 and PIASxα function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. J. Biol. Chem. 277, 41311–41317 (2002).
  Article CAS PubMed Google Scholar
• Sapetschnig, A. et al. Transcription factor Sp3 is silenced through SUMO modification by PIAS1. EMBO J. 21, 5206–5215 (2002). Provides a clear example for the role of SUMO in inhibiting transcription: PIAS1-dependent sumoylation in the inhibitory domain silences Sp3 without impairing DNA binding.
  Article CAS PubMed PubMed Central Google Scholar
• Nakagawa, K. & Yokosawa, H. PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1. FEBS Lett. 530, 204–208 (2002).
  Article CAS PubMed Google Scholar
• Sachdev, S. et al. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15, 3088–3103 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Kotaja, N., Karvonen, U., Janne, O. A. & Palvimo, J. J. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 22, 5222–5234 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Zhao, X. & Blobel, G. A SUMO ligase is part of a nuclear multiprotein complex that affects DNA repair and chromosomal organization. Proc. Natl Acad. Sci. USA 102, 4777–4782 (2005). Together with references 48 and 49 identifies Mms21/Nse2, a component of the Smc5–Smc6 complex, as a novel SP-RING-type SUMO E3 ligase.
  Article CAS PubMed PubMed Central Google Scholar
• Andrews, E. A. et al. Nse2, a component of the Smc5–6 complex, is a SUMO ligase required for the response to DNA damage. Mol. Cell. Biol. 25, 185–196 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Potts, P. R. & Yu, H. Human MMS21/NSE2 is a SUMO ligase required for DNA repair. Mol. Cell. Biol. 25, 7021–7032 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Potts, P. R. & Yu, H. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins. Nature Struct. Mol. Biol. 14, 581–590 (2007). Links sumoylation to telomerase-independent telomere maintenance in certain cancer cells.
  Article CAS Google Scholar
• Cheng, C. H. et al. SUMO modifications control assembly of synaptonemal complex and polycomplex in meiosis of Saccharomyces cerevisiae. Genes Dev. 20, 2067–2081 (2006). In addition to the description of Zip3 as a meiosis-specific SUMO E3 ligase, this paper suggests a role for SUMO-chain formation in synaptonemal-complex formation and sporulation.
  Article CAS PubMed PubMed Central Google Scholar
• Pichler, A., Gast, A., Seeler, J. S., Dejean, A. & Melchior, F. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108, 109–120 (2002). Identification of the nucleoporin RanBP2 as a unique E3 ligase, the catalytic domain of which is unrelated in sequence to HECT or RING E3 ligases (see also reference 53).
  Article CAS PubMed Google Scholar
• Pichler, A., Knipscheer, P., Saitoh, H., Sixma, T. K. & Melchior, F. The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type. Nature Struct. Mol. Biol. 11, 984–991 (2004).
  Article CAS Google Scholar
• Reverter, D. & Lima, C. D. Insights into E3 ligase activity revealed by a SUMO–RanGAP1–Ubc9–Nup358 complex. Nature 435, 687–692 (2005). A crystal structure suggests that RanBP2 functions as an E3 ligase by binding both SUMO and UBC9 to position the SUMO–E2 thioester bond in an optimal orientation to enhance conjugation.
  Article CAS PubMed PubMed Central Google Scholar
• Tatham, M. H. et al. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection. Nature Struct. Mol. Biol. 12, 67–74 (2005).
  Article CAS Google Scholar
• Kirsh, O. et al. The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J. 21, 2682–2691 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Kagey, M. H., Melhuish, T. A. & Wotton, D. The polycomb protein Pc2 is a SUMO E3. Cell 113, 127–137 (2003).
  Article CAS PubMed Google Scholar
• Kagey, M. H., Melhuish, T. A., Powers, S. E. & Wotton, D. Multiple activities contribute to Pc2 E3 function. EMBO J. 24, 108–119 (2005).
  Article CAS PubMed Google Scholar
• Zhao, X., Sternsdorf, T., Bolger, T. A., Evans, R. M. & Yao, T. P. Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. Mol. Cell. Biol. 25, 8456–8464 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Gregoire, S. & Yang, X. J. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors. Mol. Cell. Biol. 25, 2273–2287 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Ghisletti, S. et al. Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARγ. Mol. Cell 25, 57–70 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Stankovic-Valentin, N. et al. An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved ψKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol. Cell. Biol. 27, 2661–2675 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Tatham, M. H. et al. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276, 35368–35374 (2001).
  Article CAS PubMed Google Scholar
• Bylebyl, G. R., Belichenko, I. & Johnson, E. S. The SUMO isopeptidase Ulp2 prevents accumulation of SUMO chains in yeast. J. Biol. Chem. 278, 44113–44120 (2003).
  Article CAS PubMed Google Scholar
• Mukhopadhyay, D. et al. SUSP1 antagonizes formation of highly SUMO2/3-conjugated species. J. Cell Biol. 174, 939–949 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Li, S. J. & Hochstrasser, M. The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein. Mol. Cell. Biol. 20, 2367–2377 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Li, S. J. & Hochstrasser, M. A new protease required for cell-cycle progression in yeast. Nature 398, 246–251 (1999). A biochemical screen of an expression library allowed identification of the first SUMO-specific isopeptidase — Ulp1.
  Article CAS PubMed Google Scholar
• Di Bacco, A. et al. The SUMO-specific protease SENP5 is required for cell division. Mol. Cell. Biol. 26, 4489–4498 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Gong, L. & Yeh, E. T. Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. J. Biol. Chem. 281, 15869–15877 (2006).
  Article CAS PubMed Google Scholar
• Li, S. J. & Hochstrasser, M. The Ulp1 SUMO isopeptidase: distinct domains required for viability, nuclear envelope localization, and substrate specificity. J. Cell Biol. 160, 1069–1081 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Hang, J. & Dasso, M. Association of the human SUMO-1 protease SENP2 with the nuclear pore. J. Biol. Chem. 277, 19961–19966 (2002).
  Article CAS PubMed Google Scholar
• Zhang, H., Saitoh, H. & Matunis, M. J. Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol. Cell. Biol. 22, 6498–6508 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Nishida, T., Tanaka, H. & Yasuda, H. A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. Eur. J. Biochem. 267, 6423–6427 (2000).
  Article CAS PubMed Google Scholar
• Zunino, R., Schauss, A., Rippstein, P., Andrade-Navarro, M. & McBride, H. M. The SUMO protease SENP5 is required to maintain mitochondrial morphology and function. J. Cell Sci. 120, 1178–1188 (2007).
  Article CAS PubMed Google Scholar
• Gong, L., Millas, S., Maul, G. G. & Yeh, E. T. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J. Biol. Chem. 275, 3355–3359 (2000).
  Article CAS PubMed Google Scholar
• Bailey, D. & O'Hare, P. Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1. J. Biol. Chem. 279, 692–703 (2004).
  Article CAS PubMed Google Scholar
• Kim, K. I. et al. A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs. J. Biol. Chem. 275, 14102–14106 (2000).
  Article CAS PubMed Google Scholar
• Mukhopadhyay, D. & Dasso, M. Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 32, 286–295 (2007).
  Article CAS PubMed Google Scholar
• Mahajan, R., Gerace, L. & Melchior, F. Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association. J. Cell Biol. 140, 259–270 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Matunis, M. J., Wu, J. & Blobel, G. SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex. J. Cell Biol. 140, 499–509 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Kamitani, T. et al. Identification of three major sentrinization sites in PML. J. Biol. Chem. 273, 26675–26682 (1998).
  Article CAS PubMed Google Scholar
• Sternsdorf, T., Jensen, K., Reich, B. & Will, H. The nuclear dot protein Sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 274, 12555–12566 (1999).
  Article CAS PubMed Google Scholar
• Desterro, J. M., Rodriguez, M. S. & Hay, R. T. SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell 2, 233–239 (1998). Provided the first example of a protein that can be sumoylated and ubiquitylated at the same Lys residue.
  Article CAS PubMed Google Scholar
• Muller, S. et al. c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 275, 13321–13329 (2000).
  Article CAS PubMed Google Scholar
• Macauley, M. S. et al. Beads-on-a-string, characterization of ETS-1 sumoylated within its flexible N-terminal sequence. J. Biol. Chem. 281, 4164–4172 (2006).
  Article CAS PubMed Google Scholar
• Pichler, A. et al. SUMO modification of the ubiquitin-conjugating enzyme E2–25K. Nature Struct. Mol. Biol. 12, 264–269 (2005).
  Article CAS Google Scholar
• Hietakangas, V. et al. PDSM, a motif for phosphorylation-dependent SUMO modification. Proc. Natl Acad. Sci. USA 103, 45–50 (2006). Phosphorylation adjacent to the conventional SUMO-acceptor site enhances modification of several target proteins.
  Article CAS PubMed Google Scholar
• Hietakangas, V. et al. Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol. Cell. Biol. 23, 2953–2968 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, S. H., Galanis, A., Witty, J. & Sharrocks, A. D. An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J. 25, 5083–5093 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Hoege, C., Pfander, B., Moldovan, G. L., Pyrowolakis, G. & Jentsch, S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419, 135–141 (2002). Demonstrates that monoubiquitylation, polyubiquitylation and sumoylation of the same Lys residue in a non-consensus SUMO-acceptor site of PCNA serve distinct functions in DNA repair and replication (see also references 92 and 93).
  Article CAS PubMed Google Scholar
• Girdwood, D. et al. p300 transcriptional repression is mediated by SUMO modification. Mol. Cell 11, 1043–1054 (2003).
  Article CAS PubMed Google Scholar
• Papouli, E. et al. Crosstalk between SUMO and ubiquitin on PCNA is mediated by recruitment of the helicase Srs2p. Mol. Cell 19, 123–133 (2005).
  Article CAS PubMed Google Scholar
• Pfander, B., Moldovan, G. L., Sacher, M., Hoege, C. & Jentsch, S. SUMO-modified PCNA recruits Srs2 to prevent recombination during S phase. Nature 436, 428–433 (2005).
  Article CAS PubMed Google Scholar
• Zheng, G. & Yang, Y. C. ZNF76, a novel transcriptional repressor targeting TATA-binding protein, is modulated by sumoylation. J. Biol. Chem. 279, 42410–42421 (2004).
  Article CAS PubMed Google Scholar
• Lin, X. et al. Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol. Cell 11, 1389–1396 (2003).
  Article CAS PubMed Google Scholar
• Macauley, M. S. et al. Structural and dynamic independence of isopeptide-linked RanGAP1 and SUMO-1. J. Biol. Chem. 279, 49131–49137 (2004).
  Article CAS PubMed Google Scholar
• Hardeland, U., Steinacher, R., Jiricny, J. & Schar, P. Modification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnover. EMBO J. 21, 1456–1464 (2002). This work shows that cycles of SUMO modification and demodification of TDG contribute to the enzyme's function, most likely through conformational changes that allow product release and rebinding (see also reference 98).
  Article CAS PubMed PubMed Central Google Scholar
• Baba, D. et al. Crystal structure of thymine DNA glycosylase conjugated to SUMO-1. Nature 435, 979–982 (2005).
  Article CAS PubMed Google Scholar
• Minty, A., Dumont, X., Kaghad, M. & Caput, D. Covalent modification of p73α by SUMO-1. J. Biol. Chem. 275, 36316–36323 (2000).
  Article CAS PubMed Google Scholar
• Song, J., Durrin, L. K., Wilkinson, T. A., Krontiris, T. G. & Chen, Y. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl Acad. Sci. USA 101, 14373–14378 (2004). Through NMR analysis of a PIAS peptide, previously shown to bind SUMO non-covalently (see reference 99), the authors define a minimal SUMO-binding motif.
  Article CAS PubMed PubMed Central Google Scholar
• Hecker, C. M., Rabiller, M., Haglund, K., Bayer, P. & Dikic, I. Specification of SUMO1- and SUMO2-interacting motifs. J. Biol. Chem. 281, 16117–16127 (2006).
  Article CAS PubMed Google Scholar
• Hannich, J. T. et al. Defining the SUMO-modified proteome by multiple approaches in Saccharomyces cerevisiae. J. Biol. Chem. 280, 4102–4110 (2005).
  Article CAS PubMed Google Scholar
• Song, J., Zhang, Z., Hu, W. & Chen, Y. Small ubiquitin-like modifier (SUMO) recognition of a SUMO binding motif: a reversal of the bound orientation. J. Biol. Chem. 280, 40122–40129 (2005).
  Article CAS PubMed Google Scholar
• Shen, T. H., Lin, H. K., Scaglioni, P. P., Yung, T. M. & Pandolfi, P. P. The mechanisms of PML-nuclear body formation. Mol. Cell 24, 331–339 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Lin, D. Y. et al. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell 24, 341–354 (2006). Non-covalent interaction of Daxx with SUMO is required for Daxx-dependent transcriptional repression as well as for Daxx sumoylation.
  Article CAS PubMed Google Scholar
• Kuo, H. Y. et al. SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx. Proc. Natl Acad. Sci. USA 102, 16973–16978 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Prudden, J. et al. SUMO-targeted ubiquitin ligases in genome stability. EMBO J. 26, 4089–4101 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Sun, H., Leverson, J. D. & Hunter, T. Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins. EMBO J. 26, 4102–4112 (2007). This paper, together with references 107, 109 and 110, suggests that SUMO can serve as a degradation signal by recruiting a ubiquitin E3 ligase via a non-covalent SUMO–SIM/SBM interaction with its targets.
  Article CAS PubMed PubMed Central Google Scholar
• Uzunova, K. et al. Ubiquitin-dependent proteolytic control of SUMO conjugates. J. Biol. Chem. 29 Aug 2007 (doi:10.1074/jbc.M706505200).
  Article CAS Google Scholar
• Xie, Y. et al. The yeast HEX3–SLX8 heterodimer is a ubiquitin ligase stimulated by substrate sumoylation. J. Biol. Chem. 11 Sep 2007 (doi:10.1074/jbc.M706025200).
  Article CAS Google Scholar
• Hicke, L., Schubert, H. L. & Hill, C. P. Ubiquitin-binding domains. Nature Rev. Mol. Cell Biol. 6, 610–621 (2005).
  Article CAS Google Scholar
• Chupreta, S., Holmstrom, S., Subramanian, L. & Iniguez-Lluhi, J. A. A small conserved surface in SUMO is the critical structural determinant of its transcriptional inhibitory properties. Mol. Cell. Biol. 25, 4272–4282 (2005). Extensive analysis of SUMO2 mutants revealed a surface in SUMO strictly that is required for transcriptional repression. This surface is now known to interact with SIM/SBM.
  Article CAS PubMed PubMed Central Google Scholar
• Yang, S. H. & Sharrocks, A. D. SUMO promotes HDAC-mediated transcriptional repression. Mol. Cell 13, 611–617 (2004).
  Article CAS PubMed Google Scholar
• Lin, D. Y. et al. Negative modulation of androgen receptor transcriptional activity by Daxx. Mol. Cell. Biol. 24, 10529–10541 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Hay, R. T. SUMO: a history of modification. Mol. Cell 18, 1–12 (2005).
  Article CAS PubMed Google Scholar
• Bossis, G. et al. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol. Cell. Biol. 25, 6964–6979 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Lin, J. Y., Ohshima, T. & Shimotohno, K. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53. FEBS Lett. 573, 15–18 (2004).
  Article CAS PubMed Google Scholar
• Ross, S., Best, J. L., Zon, L. I. & Gill, G. SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol. Cell 10, 831–842 (2002).
  Article CAS PubMed Google Scholar
• Stelter, P. & Ulrich, H. D. Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation. Nature 425, 188–191 (2003).
  Article CAS PubMed Google Scholar
• Ulrich, H. D. Mutual interactions between the SUMO and ubiquitin systems: a plea of no contest. Trends Cell Biol. 15, 525–532 (2005).
  Article CAS PubMed Google Scholar
• Mabb, A. M., Wuerzberger-Davis, S. M. & Miyamoto, S. PIASy mediates NEMO sumoylation and NF-κB activation in response to genotoxic stress. Nature Cell Biol. 8, 986–993 (2006).
  Article CAS PubMed Google Scholar
• Huang, T. T., Wuerzberger-Davis, S. M., Wu, Z. H. & Miyamoto, S. Sequential modification of NEMO/IKKγ by SUMO-1 and ubiquitin mediates NF-κB activation by genotoxic stress. Cell 115, 565–576 (2003).
  Article CAS PubMed Google Scholar
• Shalizi, A. et al. A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science 311, 1012–1017 (2006).
  Article CAS PubMed Google Scholar
• Johnson, E. S. & Blobel, G. Cell cycle-regulated attachment of the ubiquitin-related protein SUMO to the yeast septins. J. Cell Biol. 147, 981–994 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, Y. J. et al. Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells. J. Cereb. Blood Flow Metab. 27, 950–962 (2007).
  Article CAS PubMed Google Scholar
• Kurepa, J. et al. The small ubiquitin-like modifier (SUMO) protein modification system in Arabidopsis. Accumulation of SUMO1 and -2 conjugates is increased by stress. J. Biol. Chem. 278, 6862–6872 (2003).
  Article CAS PubMed Google Scholar
• Bossis, G. & Melchior, F. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. Mol. Cell 21, 349–357 (2006). Depending on the dose, H 2 O 2 can cause global or local loss of sumoylation due to reversible crosslinking of SUMO E1 and E2 enzymes.
  Article CAS PubMed Google Scholar
• Boggio, R., Colombo, R., Hay, R. T., Draetta, G. F. & Chiocca, S. A mechanism for inhibiting the SUMO pathway. Mol. Cell 16, 549–561 (2004).
  Article CAS PubMed Google Scholar
• Boggio, R., Passafaro, A. & Chiocca, S. Targeting SUMO E1 to ubiquitin ligases: a viral strategy to counteract sumoylation. J. Biol. Chem. 282, 15376–15382 (2007). The viral protein Gam1 abolishes global sumoylation by targeting SUMO E1 for ubiquitin-mediated degradation (together with reference 128).
  Article CAS PubMed Google Scholar
• Cheng, J., Bawa, T., Lee, P., Gong, L. & Yeh, E. T. Role of desumoylation in the development of prostate cancer. Neoplasia 8, 667–676 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Mo, Y. Y., Yu, Y., Theodosiou, E., Rachel Ee, P. L. & Beck, W. T. A role for Ubc9 in tumorigenesis. Oncogene 24, 2677–2683 (2005).
  Article CAS PubMed Google Scholar
• Harder, Z., Zunino, R. & McBride, H. Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission. Curr. Biol. 14, 340–345 (2004).
  Article CAS PubMed Google Scholar
• Dadke, S. et al. Regulation of protein tyrosine phosphatase 1B by sumoylation. Nature Cell Biol. 9, 80–85 (2007). The ER-associated PTP1B is a SUMO target. In vitro assays suggest that sumoylation directly inactivates the enzyme.
  Article CAS PubMed Google Scholar
• Rajan, S., Plant, L. D., Rabin, M. L., Butler, M. H. & Goldstein, S. A. Sumoylation silences the plasma membrane leak K+ channel K2P1. Cell 121, 37–47 (2005).
  Article CAS PubMed Google Scholar
• Feliciangeli, S. et al. Does sumoylation control K2P1/TWIK1 background K+ channels? Cell 130, 563–569 (2007).
  Article CAS PubMed Google Scholar
• Benson, M. D. et al. SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5. Proc. Natl Acad. Sci. USA 104, 1805–1810 (2007). A voltage-gated potassium channel is a target for reversible sumoylation.
  Article CAS PubMed PubMed Central Google Scholar
• Wible, B. A., Yang, Q., Kuryshev, Y. A., Accili, E. A. & Brown, A. M. Cloning and expression of a novel K+ channel regulatory protein, KChAP. J. Biol. Chem. 273, 11745–11751 (1998).
  Article CAS PubMed Google Scholar
• Tang, Z., El Far, O., Betz, H. & Scheschonka, A. Pias1 interaction and sumoylation of metabotropic glutamate receptor 8. J. Biol. Chem. 280, 38153–38159 (2005).
  Article CAS PubMed Google Scholar
• Martin, S., Nishimune, A., Mellor, J. R. & Henley, J. M. SUMOylation regulates kainate-receptor-mediated synaptic transmission. Nature 447, 321–325 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Seeler, J. S., Bischof, O., Nacerddine, K. & Dejean, A. SUMO, the three Rs and cancer. Curr. Top. Microbiol. Immunol. 313, 49–71 (2007).
  CAS PubMed Google Scholar
• Dorval, V. & Fraser, P. E. SUMO on the road to neurodegeneration. Biochim. Biophys. Acta 1773, 694–706 (2007).
  Article CAS PubMed Google Scholar